Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. More Details
What is Simulations Plus's current dividend yield, its reliability and sustainability?
0.34%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: SLP's dividend (0.34%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: SLP's dividend (0.34%) is low compared to the top 25% of dividend payers in the US market (3.84%).
Stability and Growth of Payments
Stable Dividend: SLP is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: SLP is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: SLP is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SLP's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
1.3yrs
Average management tenure
CEO
Shawn O'Connor (60 yo)
2.58yrs
Tenure
US$739,400
Compensation
Mr. Shawn M. O'Connor has been Chief Executive Officer of Simulations Plus, Inc. since June 26, 2018. Mr. O'Connor served as Chief Executive Officer of Entelos, Inc. since July, 2011. Mr. O'Connor is a sea...
CEO Compensation Analysis
Compensation vs Market: Shawn's total compensation ($USD739.40K) is below average for companies of similar size in the US market ($USD3.85M).
Compensation vs Earnings: Shawn's compensation has increased by more than 20% in the past year.
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Walter Woltosz
Co-Founder & Chairman
24.5yrs
US$231.82k
23.04% $ 327.4m
Shawn O'Connor
Chief Executive Officer
2.58yrs
US$739.40k
no data
John DiBella
President of the Lancaster Division
3.33yrs
US$346.54k
0.24% $ 3.4m
John Kneisel
0.083yr
US$948.91k
0% $ 0
William Frederick
CFO & Secretary
0.083yr
no data
no data
Alexander Berg
Vice President of Operations
1.25yrs
no data
no data
Michael Bolger
Chief Scientist
no data
US$279.54k
no data
Arlene Padron
Marketing Director
no data
no data
no data
Thaddeus Grasela
Executive Vice President of Cognigen
1.33yrs
US$297.50k
no data
Scott Siler
Chief Scientific Officer of DILIsym Services
no data
no data
no data
Brett Howell
President of DILIsym Services
3.58yrs
no data
no data
Jill Fiedler-Kelly
President of Cognigen Division
no data
no data
no data
1.3yrs
Average Tenure
61yo
Average Age
Experienced Management: SLP's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Walter Woltosz
Co-Founder & Chairman
24.5yrs
US$231.82k
23.04% $ 327.4m
Daniel Weiner
Independent Director
3.67yrs
US$259.26k
0.026% $ 373.2k
Lisa LaVange
Independent Director
1.67yrs
US$257.37k
0.011% $ 152.1k
David Ralph
Independent Director
8.83yrs
US$257.15k
0.083% $ 1.2m
John Paglia
Independent Director
6.08yrs
US$269.57k
0.019% $ 271.0k
6.1yrs
Average Tenure
70yo
Average Age
Experienced Board: SLP's board of directors are considered experienced (6.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SLP insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.2%.
Top Shareholders
Company Information
Simulations Plus, Inc.'s company bio, employee growth, exchange listings and data sources
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-lea...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2021/01/15 23:39
End of Day Share Price
2021/01/15 00:00
Earnings
2020/11/30
Annual Earnings
2020/08/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.